COMPLEMENT THERAPEUTICS LIMITED

Active London

Research and experimental development on biotechnology

18 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
C

COMPLEMENT THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 12 Mar 2020 Active London, England 18 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 9 May 2026 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 17 Mar 2026 Next due 25 Mar 2027 9 months remaining
Net assets £5M £13M 2024 year on year
Total assets £8M £12M 2024 year on year
Total Liabilities £3M £835K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

4th Floor, Translation And Innovation Hub 84 Wood Lane White City London W12 0BZ England

Website

www.example.com

Full company profile for COMPLEMENT THERAPEUTICS LIMITED (12515463), an active life sciences and medical technology company based in London, England. Incorporated 12 Mar 2020. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type small
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2020–2024)

Cash in Bank

£3.96M

Decreased by £10.66M (-73%)

Net Assets

£4.57M

Decreased by £12.94M (-74%)

Total Liabilities

£3.46M

Increased by £834.80k (+32%)

Turnover

N/A

Employees

18

Increased by 8 (+80%)

Debt Ratio

43%

Increased by 30 (+231%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 3

Investors (7)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2021Seed, Series A
Investor 2Feb 2022Seed, Series A
Investor 3Apr 2023Series A

Share Capital

Share Capital

Share allotments and capital structure

13 Allotments 16,084 Shares £48.07m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
29 Jul 202515£12.96m£864k
19 Mar 20257£1.00m£1.00m
26 Jun 202325£25.00m£1.00m
9 Mar 20235,394£5.04m£934
7 Jun 2022173£0.299£0.002

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Complement Therapeutics Gmbh
100.0%
21,278

Persons with Significant Control

Persons with Significant Control (0)

No PSC information available

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
9 May 2026AccountsAnnual accounts made up to 31 Dec 2025
9 May 2026AccountsAnnual accounts made up to 31 Dec 2025
17 Mar 2026Confirmation StatementConfirmation statement made on 11 Mar 2026 with updates
8 Aug 2025CapitalAllotment of shares (GBP 0.21278) on 29 Jul 2025
30 May 2025AccountsAnnual accounts made up to 31 Dec 2024
9 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

9 May 2026 Accounts

Annual accounts made up to 31 Dec 2025

17 Mar 2026 Confirmation Statement

Confirmation statement made on 11 Mar 2026 with updates

8 Aug 2025 Capital

Allotment of shares (GBP 0.21278) on 29 Jul 2025

30 May 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

4 weeks ago on 9 May 2026

Annual accounts made up to 31 Dec 2025

4 weeks ago on 9 May 2026

Confirmation statement made on 11 Mar 2026 with updates

2 months ago on 17 Mar 2026

Allotment of shares (GBP 0.21278) on 29 Jul 2025

10 months ago on 8 Aug 2025

Annual accounts made up to 31 Dec 2024

1 years ago on 30 May 2025